anonymous
Guest
anonymous
Guest
I haven't worked pharma in 15 years, but plasma is totally different. What if we are short on product due to manufacturing and your biggest customer CANNOT get our product despite wanting it? They move to another product in order to keep their patients on therapy. We still have the quota and loss of sales. And Baxalta/immunology doesn't sample. Please go write on another thread that is more your speed.
It's painfully obvious Shire had and continues to have no idea what the immunology division does. I think the experiment is over. Everyone that is anyone is leaving or has left.